Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Bone|January 1, 1988
Newly synthesized proteoglycans in pseudoachondroplasiaM Beck, K Lingnau, J SprangerScandinavian Journal of Immunology|March 14, 2009
IC31, a two-component novel adjuvant mixed with a conjugate vaccine enhances protective immunity against pneumococcal disease in neonatal miceT A Olafsdottir, K Lingnau, E Nagy, et al.British Journal of Cancer|October 12, 2000
MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?W Walter, K Lingnau, E Schmitt, et al.The Journal of Allergy and Clinical Immunology|February 15, 2001
Local administration of antisense phosphorothioate oligonucleotides to the c-kit ligand, stem cell factor, suppresses airway inflammation and IL-4 production in a murine model of asthmaS Finotto, M Buerke, K Lingnau, et al.Immunogenetics|September 2, 2000
H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokinesW Walter, C Scheuer, K Lingnau, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 30, 1998
IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12K Lingnau, P Hoehn, S Kerdine, et al.The Journal of Investigative Dermatology|January 5, 2000
Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approachesG Müller, A Müller, H Jonuleit, et al.Pageof 1